2018 Virtual Symposium: Updates in Inflammation and Secondary CVD Prevention

Activity Title: 2018 Virtual Symposium: Updates in Inflammation and Secondary CVD Prevention

Activity Format: Virtual Symposium

Program Description:
Healthcare professionals agree on aggressive therapy for secondary prevention of CVD with statins, the cornerstone of therapy; however, recent focus has been given to the role of inflammation in the initiation and progression of atherosclerosis, the main cause of CVD, and as a treatment target for patients at risk. Observational evidence and results from clinical trials with statins have demonstrated that a reduction in inflammatory biomarkers, e.g., C-reactive protein (CRP), is associated with a reduction in cardiovascular events. A recent clinical trial has affirmed the hypothesis that reducing vascular inflammation in the absence of concomitant lipid lowering reduces the rates of cardiovascular events and demonstrated a 15% reduction in cardiovascular events compared to placebo.

During this activity, Brendan M. Everett, MD and Ishwarlal Jialal, MD, PhD will provide an overview of the role of inflammation in the pathogenesis of atherosclerosis and atherothrombotic events and residual inflammatory risks in patients with CVD. The expert faculty will focus on the role of biomarkers in assessing secondary CVD risk and review the most recent clinical trial data from the completed CANTOS study and the ongoing CIRT trial. The activity will conclude with an interactive patient case moderated by Christie M. Ballantyne, MD to demonstrate a patient at risk for secondary CVD and how managing inflammation may potentially reduce that risk. Participants will also be given the opportunity to pose questions and interact with the expert faculty during this time to enhance their knowledge and clinical practice.

Estimated Time to Complete: 1.0 hours

Release Date: July 13, 2018

Expiration Date: July 13, 2019

Credit Type(s) Available: ACCME, CDR, ACPE, ANCC

Maximum Credits: 1.0

Provided By: This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.

Commercial Supporter:
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Intended Audience:
US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.

Educational Objectives:
Upon completion of this activity, participants should be able to:

• Explain the role of inflammation in the underlying pathogenesis of the development and progression of atherosclerosis
• Identify the role of inflammatory biomarkers in the assessment of secondary CVD risk
• Review the results from clinical trials for emerging non-statin therapies targeting inflammation for the secondary prevention of CVD

Faculty Information:

Disclosure of Conflicts of Interest:

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accreditor Disclosures:

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Amanda Turner has nothing to disclose.
Erin Franceschini, MS, has nothing to disclose.
Amanda Jamrogiewicz has nothing to disclose.
Karin McAdams has nothing to disclose.

Accreditation

Physician Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement(s):

Physician Credit Designation
Global Education Group designates this virtual activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

There are 0.3 pharmacotherapy hours available for this activity

Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity. Universal Activity Number (UAN): 0530-9999-18-196-H01-P.

Dietician Accreditation Statement
Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activities / materials.

CPE Provider #GE012

Global Contact Information:

For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Instructions for CME/CE Credit:

This activity is offered at no cost to participants. During the period July 13, 2018 through July 13, 2019, participants must follow these steps in order to receive CME/CE credit:

• Sign In or Register at https://www.cardiometabolichealth.org/my-account.html
• Read and accept the Terms & Conditions including the learning objectives and faculty disclosures.
• Complete the pre-test by recording the best answer to each question in the answer key. There is no scoring of the pre-test questions section.
• Review the educational activity.
• Complete the post-test by recording the best answer to each question in the answer key. Successful completion of the post-test is required to earn CME/CE credit. Successful completion is defined as a cumulative score of at least 70%.
• Complete the online evaluation form.
• After successfully completing the post-test and online evaluation form, your CME/CE certificate will be generated and will be available immediately for print.

Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6-10 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed.

For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Hardware and Software Requirements:

This online activity must be viewed with the latest version of Chrome, Firefox or Internet Explorer. If you do not have these browsers, you can download Chrome here, Firefox here and Internet Explorer here. Optimal viewing requires a broadband connection of at least 3 Mbps and a 1 GHz processor with 1 GB RAM.